Thrombocytopenia Associated with Linezolid Therapy
Clinical Infectious Diseases2002Vol. 34(5), pp. 695–698
Citations Over TimeTop 10% of 2002 papers
Abstract
We evaluated the incidence and clinical characteristics of linezolid-induced thrombocytopenia in 19 patients who were treated with linezolid. Overall, thrombocytopenia (platelet count, 10 days; gastrointestinal bleeding was observed in 1 patient and 4 patients required platelet transfusions. These data suggest that even patients who are not considered to be at risk for development of thrombocytopenia should be monitored closely if linezolid therapy is continued for >10 days.
Related Papers
- → Rapid Emergence of Resistance to Linezolid during Linezolid Therapy of an Enterococcus faecium Infection(2006)65 cited
- → Wide dissemination of linezolid-resistant Staphylococcus epidermidis in Greece is associated with a linezolid-dependent ST22 clone(2015)28 cited
- → Linezolid-resistant Staphylococcus epidermidis associated with long-term, repeated linezolid use in a pediatric patient(2015)4 cited
- → Clinical Evaluation after a Notification Policy of Linezolid Use: A Case Series of 22 Patients(2009)2 cited
- → Linezolid-resistant Enterococcus (LRE) faecium from blood culture of an adult burns patient: First report of LRE from Mumbai(2016)1 cited